草药-药物相互作用因果评估的批判性评价
本综述基于PubMed、Cochrane Library、Medline和Scopus检索的随机或非随机临床研究、病例对照及病例报告,评估服用草药并接受处方药治疗患者中草药-药物相互作用(HDI)所致药物不良反应(ADR)的严重程度。HDI导致不同严重程度的临床ADR,患者可能对治疗药物反应不佳或发生毒性,增加治疗成本或导致/延长住院。
要点
- HDI可导致临床ADR,严重程度不一,可能表现为疗效降低或毒性增加。
- 多数报道病例涉及心血管疾病、癌症和肾移植患者,常用华法林、烷化剂和环孢素。
- 需提高患者对草药与处方药潜在相互作用及其后果的认识。
核心结论
- HDI在患者中导致不同严重程度的临床ADR,可能使患者对治疗药物反应不佳或发生毒性,增加治疗成本或导致/延长住院。
主要发现
- 多数患者诊断为心血管疾病(30.60%)、癌症(22.45%)和肾移植(16.32%),分别主要使用华法林、烷化剂和环孢素。
- HDI导致的临床ADR严重程度不一,可能表现为疗效降低或毒性增加。
关键数值与推荐
- 使用Horn药物相互作用概率量表或Roussel Uclaf因果评估方法评分系统评估HDI所致ADR的因果关系。
- 使用Stockley草药相互作用指南确定相互作用机制。
临床怎么用
- 临床应关注使用华法林、烷化剂和环孢素等药物的患者中草药-药物相互作用风险,提高患者意识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this review was to assess the severity of adverse drug reactions (ADRs) due to herb-drug interactions (HDI) in patients taking herbs and prescribed medications based on published evidence. Electronic databases of PubMed, the Cochrane Library, Medline and Scopus were searched for randomized or nonrandomized clinical studies, case-control and case reports of HDI. The data were extracted and the causal relationship of ADRs as consequences of HDI assessed using Horn's drug interaction probability scale or Roussel Uclaf Causality Assessment Method scoring systems. The mechanism of interaction was ascertained using Stockley's herbal medicine interaction companion. Forty-nine case reports and two observational studies with 15 cases of ADRs were recorded. The majority of the patients were diagnosed with cardiovascular diseases (30.60%), cancer (22.45%) and renal transplants (16.32%) receiving mostly warfarin, alkylating agents and cyclosporine, respectively. HDI occurred in patients resulting in clinical ADRs with different severity. Patients may poorly respond to therapeutic agents or develop toxicity due to severe HDI, which in either scenario may increase the cost of treatment and/or lead to or prolong patient hospitalization. It is warranted to increase patient awareness of the potential interaction between herbs and prescribed medicines and their consequences to curb HDI as a potential health problem.
引用
- Awortwe C, Makiwane M, Reuter H, et al. Critical evaluation of causality assessment of herb-drug interactions in patients. Br J Clin Pharmacol. 2018. PMID: 29363155. doi:10.1111/bcp.13490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。